The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract worth $12,645.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OGIVRI 420 MG vials. This delivery order contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The parent company of Amerisourcebergen Drug Corp is Cencora, Inc., which also does...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OGIVRI 420 MG vials. The contract, valued at $13,116.46, has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is associated with a larger indefinite delivery contract (IDC) also awarded...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $13,514.50 for the supply of OGIVRI 420 MG VIALS. The contract has an ultimate completion date of June 14, 2024 and was awarded on June 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,563,267,180 vials of the pharmaceutical product OGIVRI 420 mg. The performance location is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The potential value of this order is $5,844.06 and the period of performance ends on January 9, 2024. No set-aside designation was used for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of OGIVRI 420 MG vials, with a potential value of $13,636.14 and a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is likely part of a larger indefinite delivery contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,094.83, is for the delivery of OGIVRI 420 MG VIALS, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of December 9, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, the prime...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY5AC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $9,740.10 Firm Fixed Price delivery order is for the supply of OGIVRI 420 MG vials, a pharmaceutical product. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product, with a potential value of $21,486.02 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,659.78 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ORGOVYX 120 MG TABLET UU 30S, with a completion date of February 28, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide pharmaceutical products and medical supplies. The $554,796.94 contract has a performance period ending on January 10, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing a range of pharmaceuticals and medical materials to support Department of Defense medical programs. This...